Co-Diagnostics, Inc. (CODX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 40M 80M 120M Q1 '18: 17.4K Q2 '18: 24.6K Q3 '18: 31.7K Q4 '18: 39.9K Q1 '19: 33.6K Q2 '19: 85.5K Q3 '19: 117.2K Q4 '19: 215K Q1 '20: 1.8M Q2 '20: 25.7M Q3 '20: 47.5M Q4 '20: 74.6M Q1 '21: 93M Q2 '21: 96.3M Q3 '21: 104.6M Q4 '21: 97.9M Q1 '22: 100.6M Q2 '22: 78.2M Q3 '22: 53.2M Q4 '22: 34.2M Q1 '23: 12.1M Q2 '23: 7.3M Q3 '23: 4.7M Q4 '23: 6.8M Q1 '24: 6.7M Q2 '24: 9.1M Q3 '24: 7.3M Q4 '24: 3.9M Q1 '25: 3.5M Q2 '25: 1M Q3 '25: 507.9K Q4 '25: 622.5K Q1 '26: 718.2K Q2 '26: 721.4K Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 35M 70M 105M Q1 '18: 17.1K Q2 '18: 24.6K Q3 '18: 31.7K Q4 '18: 30.5K Q1 '19: 23.8K Q2 '19: 36.8K Q3 '19: 48.2K Q4 '19: 102.5K Q1 '20: 1.2M Q2 '20: 19.2M Q3 '20: 35.2M Q4 '20: 58M Q1 '21: 73.6M Q2 '21: 80.4M Q3 '21: 91.2M Q4 '21: 86.3M Q1 '22: 89M Q2 '22: 68.2M Q3 '22: 45.8M Q4 '22: 28.7M Q1 '23: 9.4M Q2 '23: 5.1M Q3 '23: 2.9M Q4 '23: 2.6M Q1 '24: 2.8M Q2 '24: 5.5M Q3 '24: 3.6M Q4 '24: 2.9M Q1 '25: 2.7M Q2 '25: 397.5K Q3 '25: 172.8K Q4 '25: 400.1K Q1 '26: 323.6K Q2 '26: 313.6K Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

-60M -40M -20M 0 20M 40M 60M Q4 '16: -1.7M Q1 '17: -1.8M Q2 '17: -2.1M Q3 '17: -3.5M Q4 '17: -4.6M Q1 '18: -5.3M Q2 '18: -5.9M Q3 '18: -5.8M Q4 '18: -6.1M Q1 '19: -6.1M Q2 '19: -6.1M Q3 '19: -6.1M Q4 '19: -5.9M Q1 '20: -5.7M Q2 '20: 10.4M Q3 '20: 24M Q4 '20: 41.7M Q1 '21: 53.1M Q2 '21: 50.2M Q3 '21: 51.8M Q4 '21: 46.1M Q1 '22: 45.6M Q2 '22: 29.6M Q3 '22: 9.5M Q4 '22: -27M Q1 '23: -46.8M Q2 '23: -54.6M Q3 '23: -57M Q4 '23: -42.7M Q1 '24: -43M Q2 '24: -38.7M Q3 '24: -40M Q4 '24: -40.1M Q1 '25: -38.4M Q2 '25: -38.8M Q3 '25: -35.5M Q4 '25: -50.2M Q1 '26: -50.8M Q2 '26: -49M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-60M -40M -20M 0 20M 40M 60M Q4 '16: -1.9M Q1 '17: -2.1M Q2 '17: -2.5M Q3 '17: -6M Q4 '17: -7M Q1 '18: -7.6M Q2 '18: -8.1M Q3 '18: -5.8M Q4 '18: -6.3M Q1 '19: -6.3M Q2 '19: -6.3M Q3 '19: -6.4M Q4 '19: -6.2M Q1 '20: -5.9M Q2 '20: 10.5M Q3 '20: 27.9M Q4 '20: 42.5M Q1 '21: 51.4M Q2 '21: 46.2M Q3 '21: 42M Q4 '21: 36.7M Q1 '22: 40.5M Q2 '22: 28M Q3 '22: 15.2M Q4 '22: -14.2M Q1 '23: -31.7M Q2 '23: -37.9M Q3 '23: -42.6M Q4 '23: -35.3M Q1 '24: -38.9M Q2 '24: -37.6M Q3 '24: -41.3M Q4 '24: -37.6M Q1 '25: -35.9M Q2 '25: -36M Q3 '25: -32.2M Q4 '25: -46.9M Q1 '26: -48.5M Q2 '26: -47.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 7M 14M 21M Q4 '17: 302 Q4 '19: 112.4K Q1 '20: 593.7K Q2 '20: 6.5M Q3 '20: 12.3M Q4 '20: 16.6M Q1 '21: 19.4M Q2 '21: 15.9M Q3 '21: 13.4M Q4 '21: 11.6M Q1 '22: 11.6M Q2 '22: 10M Q3 '22: 7.5M Q4 '22: 5.5M Q1 '23: 2.7M Q2 '23: 2.2M Q3 '23: 1.7M Q4 '23: 4.2M Q1 '24: 3.9M Q2 '24: 3.7M Q3 '24: 3.7M Q4 '24: 999.1K Q1 '25: 786.2K Q2 '25: 606.2K Q3 '25: 335K Q4 '25: 222.4K Q1 '26: 394.6K Q2 '26: 407.8K Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Cash Flow TTM

-40M -20M 0 20M 40M 60M Q2 '17: -1.5M Q3 '17: -2.8M Q4 '17: -3.2M Q1 '18: -3.8M Q2 '18: -4.5M Q3 '18: -4.1M Q4 '18: -4.1M Q1 '19: -4.5M Q2 '19: -4.8M Q3 '19: -4.9M Q4 '19: -5.5M Q1 '20: -5.5M Q2 '20: -3.2M Q3 '20: 6.6M Q4 '20: 28.2M Q1 '21: 41.8M Q2 '21: 53.2M Q3 '21: 56.2M Q4 '21: 41.1M Q1 '22: 36.6M Q2 '22: 25.8M Q3 '22: 15.5M Q4 '23: -22.1M Q1 '24: -24.7M Q2 '24: -24.2M Q3 '24: -25.7M Q4 '24: -29.2M Q1 '25: -29.4M Q2 '25: -32.5M Q3 '25: -31.2M Q4 '25: -29.1M Q1 '26: -28.2M Q2 '26: -27.1M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-40M -20M 0 20M 40M 60M Q2 '17: -1.6M Q3 '17: -2.9M Q4 '17: -3.3M Q1 '18: -3.9M Q2 '18: -4.5M Q3 '18: -4.2M Q4 '18: -4.1M Q2 '20: -3.4M Q3 '20: 6.3M Q4 '20: 27.4M Q1 '21: 41M Q2 '21: 52.3M Q3 '21: 55.1M Q4 '21: 40.4M Q1 '22: 35.7M Q2 '22: 24.7M Q3 '22: 14.2M Q4 '23: -23.4M Q1 '24: -26.2M Q2 '24: -25.4M Q3 '24: -26.8M Q4 '24: -29.9M Q1 '25: -29.8M Q2 '25: -33.2M Q3 '25: -31.8M Q4 '25: -29.8M Q1 '26: -29M Q2 '26: -27.5M Q1 '18 Q2 '20 Q2 '21 Q2 '22 Q2 '24 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '19: 17M Q3 '19: 17.3M Q1 '20: 22.8M Q2 '20: 29.2M Q3 '20: 29.6M Q1 '21: 30M Q2 '21: 29.7M Q3 '21: 30M Q1 '22: 34.7M Q2 '22: 32.5M Q3 '22: 31.3M Q1 '23: 29.5M Q2 '23: 29.1M Q3 '23: 29.4M Q1 '24: 29.8M Q2 '24: 30.1M Q3 '24: 30.5M Q1 '25: 1.1M Q2 '25: 1.1M Q3 '25: 37.9M Q1 '26: 2.3M Q2 '26: 4.3M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-60.00 -40.00 -20.00 0.00 20.00 40.00 60.00 Q3 '18: -0.46 Q4 '18: -0.50 Q1 '19: -0.48 Q2 '19: -0.45 Q3 '19: -0.42 Q4 '19: -0.37 Q1 '20: -0.33 Q2 '20: 0.26 Q3 '20: 0.89 Q4 '20: 1.44 Q1 '21: 1.75 Q2 '21: 1.57 Q3 '21: 1.42 Q4 '21: 1.22 Q1 '22: 1.30 Q2 '22: 0.89 Q3 '22: 0.47 Q4 '22: -0.46 Q1 '23: -1.00 Q2 '23: -1.23 Q3 '23: -1.39 Q4 '23: -1.21 Q1 '24: -1.32 Q2 '24: -1.26 Q3 '24: -1.38 Q4 '24: -37.22 Q1 '25: -43.96 Q2 '25: -50.71 Q3 '25: -50.55 Q4 '25: -48.84 Q1 '26: -45.85 Q2 '26: -40.31 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.